Nicholas Cross


Nick has advised a broad range of UK and international clients on corporate and commercial matters – from start-up/seed funding (including university spin-outs), through intermediate funding rounds (predominantly VC backed funding rounds), to exit (both private and public) – with a particular focus on the TMT and life sciences sectors.

Many of the deals Nick works on are cross-border and recent experience includes advising clinical-stage biopharmaceutical company NuCana on the UK aspects of its IPO on Nasdaq. Nick has also gained valuable commercial experience having spent three months on secondment to the in-house legal department of Capgemini plc, a multinational technology and outsourcing company.


  • BA Theology and Religious Studies with Management Studies, University of Cambridge
  • Qualified 2015


Biotech Review of the Year

Read here

Related Articles